These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7185550)

  • 1. Neuroleptic withdrawal behavior--cases of rebound cholinergic supersensitivity.
    Inoue F
    Clin Pharm; 1982; 1(6):567-9. PubMed ID: 7185550
    [No Abstract]   [Full Text] [Related]  

  • 2. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports.
    Sovner R
    Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal akinesia.
    Inoue F; Janikowski AM
    J Neurol Neurosurg Psychiatry; 1981 Oct; 44(10):958. PubMed ID: 7310414
    [No Abstract]   [Full Text] [Related]  

  • 4. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    Gross EJ; Hull HG; Lytton GJ; Hill JA; Piersel WC
    Am J Ment Retard; 1993 Jul; 98(1):156-64. PubMed ID: 8103997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome.
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):128-9. PubMed ID: 6407706
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of akathisia.
    Kumar BB
    Am J Psychiatry; 1979 Aug; 136(8):1088. PubMed ID: 464141
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of both tardive dystonia and akathisia after botulinum toxin injection.
    Shulman LM; Singer C; Weiner WJ
    Neurology; 1996 Mar; 46(3):844-5. PubMed ID: 8618701
    [No Abstract]   [Full Text] [Related]  

  • 10. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of chronic chlorpromazine medication: an experimental analysis.
    Marholin D; Touchette PE; Stewart RM
    J Appl Behav Anal; 1979; 12(2):159-71. PubMed ID: 489476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal symptoms after long-term treatment with neuroleptics.
    Krystof J; Zyg J; Mitkiewicz S; Kaczyński J
    Pol Med J; 1972; 11(1):189-95. PubMed ID: 5040995
    [No Abstract]   [Full Text] [Related]  

  • 13. Meige's syndrome associated with neuroleptic treatment.
    Ananth J; Edelmuth E; Dargan B
    Am J Psychiatry; 1988 Apr; 145(4):513-5. PubMed ID: 2894781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic exacerbation of phenothiazine-induced extrapyramidal syndrome.
    Alpert M; Diamond F; Laski EM
    Am J Psychiatry; 1976 Sep; 133(9):1073-5. PubMed ID: 961932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
    Bullock RJ
    Med J Aust; 1972 Aug; 2(6):314-6. PubMed ID: 4404280
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.
    Adler LA; Peselow E; Rosenthal M; Angrist B
    Psychopharmacol Bull; 1993; 29(2):283-6. PubMed ID: 8290678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problem of tardive akathisia.
    Gualtieri CT
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.